Diabetes Clinic
UCSF ranks among the top pediatric hospitals in the nation for diabetes and endocrinology care, according to U.S. News & World Report. At our Pediatric Diabetes Clinic, our team of experts – including endocrinologists, certified diabetes educators, registered dietitians, social workers, child psychologists and child life specialists – cares for children with type 1 and type 2 diabetes from birth to age 21.
We recognize that managing diabetes in children is about more than food and insulin, so we also pay careful attention to the medical and emotional needs of our patients and their families. We create treatment regimens that suit each family’s needs and culture, and offer classes and one-on-one sessions to help parents and other caregivers choose and master the latest technologies. Our Transition Program prepares teens to manage their diabetes independently, and because needs change over time, we build lifelong relationships with our families, making sure our patients continue to get the best care at every stage.
We also maintain an active research program that emphasizes immune modulation therapy to prevent or cure diabetes, stem cell generation of beta cells, and studies on optimizing the use of current device technology and diabetes data.
Our locations (6)
Our team
-
Tariq Ahmad
MD
Endocrinology, Pediatric Endocrinology -
Sonali Belapurkar
MD
Pediatric Endocrinology -
Gina Capodanno
MD, MS
Pediatric Endocrinology, Endocrinology -
Eda Cengiz
MD
Pediatric Endocrinology -
Hannah Chesser
MD
Pediatric Endocrinology -
Aristides Diamant
MD
Pediatric Endocrinology -
Laya Ekhlaspour
MD
Pediatric Endocrinology -
Ayca Erkin-Cakmak
MD, MPH
Endocrinology, Pediatric Endocrinology -
Stephen E. Gitelman
MD
Pediatric Endocrinology, Endocrinology -
Tina Hu
MD
Pediatric Endocrinology -
Elaine Ku
MD
Pediatric Nephrology, Nephrology -
Maya Lodish
MD, MS
Pediatric Endocrinology -
Roger Long
MD
Pediatric Endocrinology, Endocrinology -
Jennifer Olson
MD
Pediatric Endocrinology -
Alison Reed
MD
Pediatrics, Pediatric Endocrinology -
Sujatha Seetharaman
MD
Pediatric Endocrinology -
Shylaja Srinivasan
MD
Pediatric Endocrinology, Endocrinology -
Martin Thelin
MD
Pediatric Endocrinology -
Patrika M. Tsai
MD, MPH
Pediatric Gastroenterology -
Jenise Wong
MD, PhD
Pediatric Endocrinology, Endocrinology -
Kevin Yen
MD
Pediatrics, Endocrinology -
Anita Markoff
NP
Pediatric Endocrinology -
Nicole Rotter
NP
Pediatric Endocrinology
Awards & recognition
-
One of the nation's best for endocrinology & diabetes care
-
Ranked among the nation's best in 11 specialties
-
Center of excellence for diabetes research (Juvenile Diabetes Research Foundation)
Recommended reading
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your child's condition
- List of medications, including dosages, plus any your child is allergic to
- List of questions you may have
- Device or paper for taking notes
Related clinics (3)
Support services
Clinical trials
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimum...
The primary outcome is the C-peptide in response to a 2-hour MMTT at week 104. This is measured as the area under the stimulated C-peptide curve (AUC). AUC is computed using a trapezoidal rule, which is a weighted sum of the C-pep...
Recruiting
More about this studyPRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation ...
This is a measure of endogenous insulin production and β cell function (change from baseline in C-peptide ln [AUC+1].
Recruiting
More about this studyTrialNet Pathway to Prevention of T1D
The primary outcome is the development of diabetes as defined by the American Diabetes Association (ADA) based on glucose testing, or the presence of symptoms and unequivocal hyperglycemia.
Recruiting
More about this studyStudy to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous F...
Evaluate the effect of inclisiran compared to placebo on reducing LDL-C [percent change] at Day 330
Recruiting
More about this studyStudy to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hype...
Demonstrate superiority of inclisiran compared to placebo in reducing LDL-C [percent change] at Day 330
Recruiting
More about this studyType 1 Diabetes Extension Study
Evaluation of changes in beta cell function over time will be measured by mixed-meal tolerance test (MMTT) -Stimulated mean C-Peptide area under the curve (AUC). C-peptide is released by the pancreas into the bloodstream in equal...
Recruiting
More about this studyRezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
The primary outcome of each participant is the mean area under the stimulated C-peptide curve (AUC) over the 2-hour mixed meal glucose tolerance test conducted at the 12-month visit in nmol/L, denoted as Y_MAUC.
Recruiting
More about this studyA Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diab...
A summary of treatment emergent adverse events (TEAEs), SAEs and other non-serious adverse events (AEs), regardless of causality, will be reported in the Reported Adverse Events module
Recruiting
More about this studyINHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Percentage of participants with a CGM-measured TIR 70-180 mg/dL ≥70% during 14 days prior to 13-week visit
Recruiting
More about this studyPrecision Dosing of Metformin in Youth With T2D
The perception that a higher dose of Metformin is agreeable or satisfactory measured with the 4-item Acceptability of Intervention Measure (AIM). A 4-item measure of perceived intervention acceptability. Items are measured on a 5-...
Recruiting
More about this studyOur research initiatives
Soothing the soul
Our music therapy program nurtures patients with bedside serenades, rap workshops and more.
Find out more
